Technologies used in evaluation of diabetic foot ulcer risk

Öz

Diabetic foot ulcers are one of the most serious complications of diabetes. It has been reported that about half of people who develop diabetic foot ulcers develop ulcers again within the first year. Various health technologies have been developed to prevent diabetic foot ulcers, to detect them early and to speed up the healing process. In this review, the effect of developed technological systems on diabetic foot ulcers is explained. Early sensory loss can be detected by neuropathy tests with monofilaments. Peripheral arterial disease can be determined in the early period with the developed Laser Doppler Flowmeter system. Infections that may occur through the sensor that detects increases in foot temperature can be noticed at an early stage. Plantar insoles detect sudden pressure changes in the foot and send alerts to paired smart devices. With tele-health applications, remote glucose monitoring, foot care training, foot controls can be provided and patients can be followed closely. Tele-health applications have been reported to be a cost-effective and comfortable method for patients. These developed technologies will provide great support to the care and treatment process of health care professionals. In addition, with these developed systems, early diagnosis of patients will be ensured and worsening of the prognosis will be prevented.

Anahtar Kelimeler

• Diabetic foot ulcer
• diabetes
• wearable technologies
• diabetes technologies

Proje Numarası

YOKTUR.

Diyabetik ayak ülseri riskinin değerlendirilmesinde kullanılan teknolojiler

Öz

Diyabetik ayak ülserleri diyabetin en ciddi komplikasyonlarından biridir. Diyabetik ayak ülseri gelişen kişilerin yaklaşık yarısında ilk bir yıl içinde tekrar ülser geliştiği bildirilmiştir. Diyabetik ayak ülserlerini önlemek, erken fark etmek ve iyileşme sürecini hızlandırmak için çeşitli sağlık teknolojileri geliştirilmiştir. Bu derlemede geliştirilmiş teknolojik sistemlerin diyabetik ayak ülserleri üzerine etkisi anlatılmıştır. Monofilamantlar ile yapılan nöropati testleri ile erken dönemde duyu kaybı tespit edilebilmektedir. Geliştirilen Lazer Doppler Flowmetre sistemiyle erken dönemde periferik arter hastalığı belirlenebilmektedir. Ayak sıcaklığında meydana gelen artışları algılayan sensör aracılığıyla meydana gelebilecek enfeksiyonlar erken dönemde fark edilebilmektedir. Plantar tabanlıklar ayaktaki ani basınç değişimlerini algılayarak eşleştirilen akıllı cihazlara uyarı gönderimi sağlamaktadır. Tele-sağlık uygulamalarıyla uzaktan glukoz takibi, ayak bakımı eğitimi, ayak kontrollerinin yapılması sağlamakta ve hastalar yakın takip edilmektedir. Tele-sağlık uygulamaları hastalar açısından uygun maliyetli ve konforlu bir yöntem olduğu bildirilmiştir. Bu geliştirilen teknolojiler sağlık bakım profesyonellerinin bakım ve tedavi sürecine büyük destek sağlayacaktır. Ayrıca geliştirilen bu sistemler ile hastaların erken tanı alması sağlanarak prognozun kötüleşmesinin önüne geçilmiş olacaktır.

Anahtar Kelimeler

• Diyabetik ayak ülseri
• diyabet
• giyilebilir teknolojiler
• diyabet teknolojileri

Destekleyen Kurum

YOKTUR.

Proje Numarası

YOKTUR.

Teşekkür

Emeğiniz için teşekkür ederiz.

Kaynakça

1. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
2. Ulusal Diyabet Konsensus Grubu. Diyabet Tanı ve Tedavi Rehberi 2019. İstanbul: Armoni Nüans Baskı Sanatları AŞ. https://www.turkdiab.org/admin/PICS/files/Diyabet_Tani_ve_Tedavi_Rehberi_2019.pdf. 01.09.2022 tarihinde erişilmiştir.
3. Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
4. Raghav A, Khan ZA, Labala RK, Ahmad J, Noor S, Mishra BK. Financial burden of diabetic foot ulcers to world: a progressive topic to discuss always. Ther Adv Endocrinol Metab. 2018;9(1):29-31. doi:10.1177/2042018817744513
5. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. N Engl J Med. 2017;376(24):2367-2375. doi:10.1056/NEJMra1615439
6. Driver VR, Fabbi M, Lavery LA, Gibbons G. The costs of diabetic foot: the economic case for the limb salvage team [published correction appears in J Vasc Surg. 2010 Dec;52(6):1751]. J Vasc Surg. 2010;52(3 Suppl):17S-22S. doi:10.1016/j.jvs.2010.06.003
7. Bandyk DF. The diabetic foot: Pathophysiology, evaluation, and treatment. Semin Vasc Surg. 2018;31(2-4):43-48. doi:10.1053/j.semvascsurg.2019.02.001
8. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG. Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med. 1998;158(2):157-162. doi:10.1001/archinte.158.2.157

9. Van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil. 2010;17 Suppl 1:S3-S8. doi:10.1097/01.hjr.0000368191.86614.5a
10. Apelqvist J. Diagnostics and treatment of the diabetic foot. Endocrine. 2012;41(3):384-397. doi:10.1007/s12020-012-9619-x
11. Bernstein RK. Physical signs of the intrinsic minus foot. Diabetes Care. 2003;26(6):1945-1946. doi:10.2337/diacare.26.6.1945
12. McDermott MM, Liu K, Ferrucci L, et al. Circulating blood markers and functional impairment in peripheral arterial disease. J Am Geriatr Soc. 2008;56(8):1504-1510. doi:10.1111/j.1532-5415.2008.01797.x
13. Jan YK, Shen S, Foreman RD, Ennis WJ. Skin blood flow response to locally applied mechanical and thermal stresses in the diabetic foot. Microvasc Res. 2013;89:40-46. doi:10.1016/j.mvr.2013.05.004
14. Boulton AJ, Armstrong DG, Albert SF, et al. Comprehensive foot examination and risk assessment: a report of the task force of the foot care interest group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care. 2008;31(8):1679-1685. doi:10.2337/dc08-9021
15. Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, diagnosis and classification. Am Fam Physician. 1998;57(6):1325-1338.
16. Armstrong DG. The 10-g monofilament: the diagnostic divining rod for the diabetic foot?. Diabetes Care. 2000;23(7):887. doi:10.2337/diacare.23.7.887
17. Cao P, Eckstein HH, De Rango P, et al. Chapter II: Diagnostic methods. Eur J Vasc Endovasc Surg. 2011;42 Suppl 2:S13-S32. doi:10.1016/S1078-5884(11)60010-5
18. Wu SC, Driver VR, Wrobel JS, Armstrong DG. Foot ulcers in the diabetic patient, prevention and treatment. Vasc Health Risk Manag. 2007;3(1):65-76.
19. Lung CW, Wu FL, Liao F, Pu F, Fan Y, Jan YK. Emerging technologies for the prevention and management of diabetic foot ulcers. J Tissue Viability. 2020;29(2):61-68. doi:10.1016/j.jtv.2020.03.003
20. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26(12):3333-3341. doi:10.2337/diacare.26.12.3333.
21. Jan YK, Liao F, Cheing GLY, Pu F, Ren W, Choi HMC. Differences in skin blood flow oscillations between the plantar and dorsal foot in people with diabetes mellitus and peripheral neuropathy. Microvasc Res. 2019;122:45-51. doi:10.1016/j.mvr.2018.11.002
22. Liao F, Burns S, Jan YK. Skin blood flow dynamics and its role in pressure ulcers. J Tissue Viability. 2013;22(2):25-36. doi:10.1016/j.jtv.2013.03.001
23. Bus SA. Innovations in plantar pressure and foot temperature measurements in diabetes. Diabetes Metab Res Rev. 2016;32 Suppl 1:221-226. doi:10.1002/dmrr.2760
24. Jennett PA, Affleck Hall L, Hailey D, et al. The socio-economic impact of telehealth: a systematic review. J Telemed Telecare. 2003;9(6):311-320. doi:10.1258/135763303771005207
25. Esmatjes E, Jansà M, Roca D, et al. The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study. Diabetes Technol Ther. 2014;16(7):435-441. doi:10.1089/dia.2013.0313
26. González-Molero I, Domínguez-López M, Guerrero M, et al. Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring. J Telemed Telecare. 2012;18(6):328-332. doi:10.1258/jtt.2012.120103
27. Smith-Strøm H, Igland J, Østbye T, et al. The Effect of Telemedicine Follow-up Care on Diabetes-Related Foot Ulcers: A Cluster-Randomized Controlled Noninferiority Trial. Diabetes Care. 2018;41(1):96-103. doi:10.2337/dc17-1025
28. Van Netten JJ, Clark D, Lazzarini PA, Janda M, Reed LF. The validity and reliability of remote diabetic foot ulcer assessment using mobile phone images. Sci Rep. 2017;7(1):9480. Published 2017 Aug 25. doi:10.1038/s41598-017-09828-4
29. Rogers LC, Lavery LA, Joseph WS, Armstrong DG. All Feet On Deck-The Role of Podiatry During the COVID-19 Pandemic: Preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes [published online ahead of print, 2020 Mar 25]. J Am Podiatr Med Assoc. 2020;10.7547/20-051. doi:10.7547/20-051
30. Yavuz M, Brem RW, Glaros AG, et al. Association Between Plantar Temperatures and Triaxial Stresses in Individuals With Diabetes. Diabetes Care. 2015;38(11):e178-e179. doi:10.2337/dc15-1147.
31. Rothenberg GM, Page J, Stuck R, Spencer C, Kaplan L, Gordon I. Remote Temperature Monitoring of the Diabetic Foot: From Research to Practice. Fed Pract. 2020;37(3):114-124.
32. Frykberg RG, Gordon IL, Reyzelman AM, et al. Feasibility and Efficacy of a Smart Mat Technology to Predict Development of Diabetic Plantar Ulcers. Diabetes Care. 2017;40(7):973-980. doi:10.2337/dc16-2294
33. Reyzelman AM, Koelewyn K, Murphy M, et al. Continuous Temperature-Monitoring Socks for Home Use in Patients With Diabetes: Observational Study. J Med Internet Res. 2018;20(12):e12460. Published 2018 Dec 17. doi:10.2196/12460
34. Lazzarini PA, Crews RT, van Netten JJ, et al. Measuring Plantar Tissue Stress in People With Diabetic Peripheral Neuropathy: A Critical Concept in Diabetic Foot Management. J Diabetes Sci Technol. 2019;13(5):869-880. doi:10.1177/1932296819849092
35. Van Netten JJ, Woodburn J, Bus SA. The future for diabetic foot ulcer prevention: A paradigm shift from stratified healthcare towards personalized medicine. Diabetes Metab Res Rev. 2020;36 Suppl 1:e3234. doi:10.1002/dmrr.3234
36. Ferber R, Webber T, Everett B, Groenland M. Validation of plantar pressure measurements for a novel in-shoe plantar sensory replacement unit. J Diabetes Sci Technol. 2013;7(5):1167-1175. Published 2013 Sep 1. doi:10.1177/193229681300700535
37. Hasan R, Firwana B, Elraiyah T, et al. A systematic review and meta-analysis of glycemic control for the prevention of diabetic foot syndrome. J Vasc Surg. 2016;63(2 Suppl):22S-28S.e2. doi:10.1016/j.jvs.2015.10.005
38. Alshammari M, Windle R, Bowskill D, Adams, G. The role of nurses in diabetes care: a qualitative study. Open Journal of Nursing. 2021;11(8);682-695.
39. Nikitara M, Constantinou CS, Andreou E, Diomidous M. The role of nurses and the facilitators and barriers in diabetes care: a mixed methods systematic literature review. Behavioral sciences. 2019: 9(6);61. doi: 10.4236/ojn.2021.118058
40. Aalaa M, Malazy OT, Sanjari M, Peimani M, Mohajeri-Tehrani M. Nurses' role in diabetic foot prevention and care; a review. J Diabetes Metab Disord. 2012;11(1):24. Published 2012 Nov 21. doi:10.1186/2251-6581-11-24